Search Results - Mithun V. Shah
- Showing 1 - 12 results of 12
-
1
Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms by Gaurav Goyal, Aishwarya Ravindran, Yuanhang Liu, Rong He, Mithun V. Shah, N. Nora Bennani, Mrinal M. Patnaik, Karen L. Rech, Ronald S. Go
Published in Haematologica (2020-02-01)Get full text
Article -
2
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease by Gaurav Goyal, Aishwarya Ravindran, Jason R. Young, Mithun V. Shah, N. Nora Bennani, Mrinal M. Patnaik, Grzegorz S. Nowakowski, Gita Thanarajasingam, Thomas M. Habermann, Robert Vassallo, Taimur Sher, Sameer A. Parikh, Karen L. Rech, Ronald S. Go
Published in Haematologica (2020-02-01)Get full text
Article -
3
Sirolimus as frontline therapy for <i>PTEN</i>-mutated histiocytic sarcoma by Karan L. Chohan, Jithma P. Abeykoon, Jason R. Young, W. Oliver Tobin, Mathew J. Koster, Mithun V. Shah, Jay H. Ryu, Robert Vassallo, Karen L. Rech., Aishwarya Ravindran, Gaurav Goyal, Ronald S. Go, N. Nora Bennani
Published in Haematologica (2022-12-01)Get full text
Article -
4
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders by Saurabh Zanwar, Jithma P. Abeykoon, Surendra Dasari, Aishwarya Ravindran, Jason R. Young, Aldo A. Acosta-Medina, Karen L. Rech, Jonathan Schwartz, Aaron Mangold, Allison Rosenthal, N. Nora Bennani, Mithun V. Shah, Diana Morlote, Gaurav Goyal, Ronald S. Go
Published in Blood Cancer Journal (2022-06-01)Get full text
Article -
5
Clinical Outcome and Molecular Profile in Patients with <i>DDX41</i> Mutation Hot-Spots by Nadia Toumeh, Yazan Jabban, Ahmad Nanaa, Rong He, David Viswanatha, Dragan Jevremovic, James M. Foran, Cecilia Y. Arana Yi, Antoine N. Saliba, Mehrdad Hefazi Torghabeh, William J. Hogan, Mithun V. Shah, Abhishek A. Mangaonkar, Mrinal M. Patnaik, Hassan B. Alkhateeb, Aref Al-Kali
Published in Hematology Reports (2025-05-01)Get full text
Article -
6
Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm by Naseema Gangat, Rimal Ilyas, Kristen McCullough, Kebede H. Begna, Aref Al-Kali, Mrinal M. Patnaik, Mark R. Litzow, William J. Hogan, Abhishek Mangaonkar, Hassan Alkhateeb, Mithun V. Shah, Michelle A. Elliott, James M. Foran, Talha Badar, Jeanne M. Palmer, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi
Published in Haematologica (2022-12-01)Get full text
Article -
7
Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features by Mihir D. Wechalekar, Lin-Pierre Zhao, Monika M. Kutyna, Lih En Hong, Joule Li, Kevin Hung, Hamish S. Scott, Anna Brown, Christopher C. Hahn, Karin Kassahn, Dariusz Ladon, David T. Yeung, Daniel Thomas, Mrinal Patnaik, Susanna Proudman, Lionel Ades, Mithun V. Shah, Chung H. Kok, Devendra K. Hiwase
Published in Blood Cancer Journal (2024-07-01)Get full text
Article -
8
Genetic landscape and clinical outcomes of patients with <i>BCOR</i> mutated myeloid neoplasms by Anmol Baranwal, Mark Gurney, Rami Basmaci, Bahga Katamesh, Rong He, David S. Viswanatha, Patricia Greipp, James Foran, Talha Badar, Hemant Murthy, Cecilia Arana Yi, Jeanne Palmer, Abhishek A. Mangaonkar, Mrinal M. Patnaik, Mark R. Litzow, William J. Hogan, Kebede Begna, Naseema Gangat, Ayalew Tefferi, Aref Al-Kali, Mithun V. Shah, Hassan B. Alkhateeb
Published in Haematologica (2024-02-01)Get full text
Article -
9
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) by Mostafa Abdallah, Kristen McCullough, Rimal Ilyas, Kebede H. Begna, Aref Al-Kali, Mark R. Litzow, William J. Hogan, Abhishek Mangaonkar, Hassan Alkhateeb, Mithun V. Shah, Michelle A. Elliott, James M. Foran, Talha Badar, Jeanne M. Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mrinal M. Patnaik, Horatiu Olteanu, Rhett P. Ketterling, Ayalew Tefferi, Naseema Gangat
Published in Blood Cancer Journal (2023-03-01)Get full text
Article -
10
FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(<i>DEK::NUP214</i>): The Mayo Clinic experience by Clifford M. Csizmar, Antoine N. Saliba, Patricia T. Greipp, Hassan Alkhateeb, Kebede H. Begna, James M. Foran, Naseema Gangat, William J. Hogan, C. Christopher Hook, Mark R. Litzow, Abhishek A. Mangaonkar, Jeanne M. Palmer, Animesh Pardanani, Mithun V. Shah, Ayalew Tefferi, Mehrdad Hefazi Torghabeh, Alexandra P. Wolanskyj-Spinner, Mrinal M. Patnaik, Scott H Kaufmann, Aref Al-Kali
Published in Haematologica (2024-06-01)Get full text
Article -
11
Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms by Samantha A. Banks, Paul Decker, Eoin P. Flanagan, Anastasia Zekeridou, Ronald S. Go, Jithma P. Abeykoon, Gaurav Goyal, Jason R. Young, Matthew J. Koster, Robert Vassallo, Jay H. Ryu, Caroline J. Davidge-Pitts, Aishwarya Ravindran, Julio C. Sartori Valinotti, N. Nora Bennani, Mithun V. Shah, Karen L. Rech, Corrie R. Bach, Jeanette E. Eckel-Passow, W. Oliver Tobin, the Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group and Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic
Published in Blood Cancer Journal (2024-09-01)Get full text
Article -
12
Clinical features and outcomes in primary nervous system histiocytic neoplasms by Nabeela Nathoo, Joon H. Uhm, Alyx B. Porter, Julie Hammack, Kurt A. Jaeckle, Maciej M. Mrugala, Brian A. Crum, Eoin P. Flanagan, Sean J. Pittock, Gaurav Goyal, Jason R. Young, Matthew J. Koster, Robert Vassallo, Jay H. Ryu, Caroline J. Davidge-Pitts, Corrie Bach, Aishwarya Ravindran, Julio C. Sartori Valinotti, N. Nora Bennani, Jithma P. Abeykoon, Mithun V. Shah, C. Christopher Hook, Karen L. Rech, Ronald S. Go, W. Oliver Tobin, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group
Published in Blood Cancer Journal (2024-06-01)Get full text
Article